Pictet Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.97M | Sell |
147,721
-174,393
| -54% | -$8.23M | 0.01% | 729 |
|
|
2025
Q1 | $12.6M | Sell |
322,114
-24,503
| -7% | -$957K | 0.01% | 601 |
|
|
2024
Q4 | $18.8M | Sell |
346,617
-10,219
| -3% | -$553K | 0.02% | 520 |
|
|
2024
Q3 | $18M | Buy |
356,836
+10,996
| +3% | +$554K | 0.02% | 517 |
|
|
2024
Q2 | $15.2M | Sell |
345,840
-154,001
| -31% | -$6.77M | 0.02% | 540 |
|
|
2024
Q1 | $25.1M | Sell |
499,841
-116,722
| -19% | -$5.86M | 0.03% | 440 |
|
|
2023
Q4 | $37.2M | Buy |
616,563
+74,662
| +14% | +$4.51M | 0.04% | 357 |
|
|
2023
Q3 | $30.9M | Buy |
+541,901
| New | +$30.9M | 0.04% | 363 |
|